An outbreak of invasive group A streptococcal disease associated with high carriage rates of the invasive clone among school-aged children.

OBJECTIVES To determine if a common strain of group A streptococcus was responsible for an outbreak of invasive streptococcal disease in southeastern Minnesota and to determine whether this strain was prevalent among residents of this area during the outbreak who either had streptococcal pharyngitis or were asymptomatic streptococcal carriers. DESIGN Pharyngeal culture survey and case-contact evaluation. SETTING Three adjacent counties in southeastern Minnesota defined as the outbreak area. Outbreak period, January 1 through March 31, 1995. PATIENTS Seven patients with invasive streptococcal infection, 1249 patients (adults and children) with sore throat who resided in the outbreak area, children from an elementary school located in 1 community where the majority of invasive cases occurred, and 896 students from 3 schools located in Minnesota counties outside the outbreak area. MEASUREMENTS Pulsed-field gel electrophoresis (DNA fingerprinting) of group A streptococcal isolates obtained from patients with invasive disease, throat swabs of patients with sore throat, and throat swabs of asymptomatic school-aged children. RESULTS All patients with outbreak-associated invasive disease had group A streptococcal isolates that were indistinguishable by pulsed-field gel electrophoresis. Additional testing showed that these isolates carried significant virulence factors including pyrogenic exotoxin A and streptococcal superantigen. Five of these 7 patients with invasive disease had underlying medical conditions; 4 developed toxic shock syndrome and died (case fatality, 57%). The outbreak-associated group A streptococcal clone was found in 69 (26.5%) of the 260 patients with sore throat from whom group A streptococcus was isolated. The frequency of the outbreak clone among pharyngeal carriers from the 3 schools outside the outbreak area was significantly less (range, 0%-10%) than in children from the school in the outbreak area (78%; relative risk, 29; 95% confidence interval, 11.1-78.1; P<.001). Four of the 7 patients with outbreak-associated disease had contact with children who attended the school in the outbreak area. CONCLUSIONS A single clone of group A streptococcus was responsible for 7 cases of invasive streptococcal disease during an outbreak in Minnesota and for a significant number of pharyngitis cases that also occurred during the outbreak. Invasive disease occurred most frequently in persons with underlying medical conditions. This outbreak was also associated with increased carriage rates of the invasive streptococcal clone among community school-aged children. Cases of invasive group A streptococcal infection may therefore reflect the tip of the iceberg with regard to the burden of colonization of a specific invasive streptococcal clone in a community.

[1]  D E Low,et al.  Invasive group A streptococcal infections in Ontario, Canada. Ontario Group A Streptococcal Study Group. , 1996, The New England journal of medicine.

[2]  C. Collins,et al.  Analysis of the superantigenic activity of mutant and allelic forms of streptococcal pyrogenic exotoxin A , 1996, Infection and immunity.

[3]  D. Stevens Streptococcal toxic-shock syndrome: spectrum of disease, pathogenesis, and new concepts in treatment. , 1995, Emerging infectious diseases.

[4]  D. Mevorach,et al.  Group A streptococcus bacteremia at the Hadassah Medical Center in Jerusalem. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[5]  W. Gruber,et al.  Group A streptococcal necrotizing fasciitis following varicella in children: case reports and review. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[6]  J. Musser,et al.  Genetic diversity and relationships among Streptococcus pyogenes strains expressing serotype M1 protein: recent intercontinental spread of a subclone causing episodes of invasive disease , 1995, Infection and immunity.

[7]  J. Musser,et al.  Molecular characterization and phylogenetic distribution of the streptococcal superantigen gene (ssa) from Streptococcus pyogenes , 1994, Infection and immunity.

[8]  J. Musser,et al.  Real-time molecular epidemiologic analysis of an outbreak of Streptococcus pyogenes invasive disease in US Air Force trainees. , 1994, Archives of pathology & laboratory medicine.

[9]  J. Musser,et al.  A conserved Streptococcus pyogenes extracellular cysteine protease cleaves human fibronectin and degrades vitronectin. , 1993, Microbial pathogenesis.

[10]  B. Schwartz,et al.  Association of phenotypic and genotypic characteristics of invasive Streptococcus pyogenes isolates with clinical components of streptococcal toxic shock syndrome , 1993, Infection and immunity.

[11]  M. P. Harbaugh,et al.  Nucleotide substitutions and small‐scale insertion produce size and antigenic variation in group A streptococcal M1 protein , 1993, Molecular microbiology.

[12]  D. Mathai,et al.  Toxic strep syndrome. , 1993, The Journal of the Association of Physicians of India.

[13]  D. Musher,et al.  Geographic and temporal distribution and molecular characterization of two highly pathogenic clones of Streptococcus pyogenes expressing allelic variants of pyrogenic exotoxin A (Scarlet fever toxin). , 1993, The Journal of infectious diseases.

[14]  B. Schwartz,et al.  The changing epidemiology of invasive group A streptococcal infections and the emergence of streptococcal toxic shock-like syndrome. A retrospective population-based study. , 1993, JAMA.

[15]  J. P. Davis,et al.  Defining the group A streptococcal toxic shock syndrome. Rationale and consensus definition. The Working Group on Severe Streptococcal Infections. , 1993, JAMA.

[16]  Dwight R. Johnson,et al.  Epidemiologic analysis of group A streptococcal serotypes associated with severe systemic infections, rheumatic fever, or uncomplicated pharyngitis. , 1992, The Journal of infectious diseases.

[17]  J. Karp Outbreak of group a streptococcus septicemia in children , 1992 .

[18]  A. Adimora,et al.  Outbreak of invasive group A streptococcal infections in a nursing home. Lessons on prevention and control. , 1992, Archives of internal medicine.

[19]  M. Pichichero,et al.  Streptococcus pyogenes pharyngitis: characterization of strains by multilocus enzyme genotype, M and T protein serotype, and pyrogenic exotoxin gene probing , 1992, Journal of clinical microbiology.

[20]  D. Stevens Invasive group A streptococcus infections. , 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[21]  K. Singh,et al.  DNA fingerprinting of Enterococcus faecium by pulsed-field gel electrophoresis may be a useful epidemiologic tool , 1991, Journal of clinical microbiology.

[22]  J. Musser,et al.  Characterization and clonal distribution of four alleles of the speA gene encoding pyrogenic exotoxin A (scarlet fever toxin) in Streptococcus pyogenes , 1991, The Journal of experimental medicine.

[23]  A. Bisno Group A streptococcal infections and acute rheumatic fever. , 1991, The New England journal of medicine.

[24]  L. Burman,et al.  Outbreak of group A streptococcal bacteremia in Sweden: an epidemiologic and clinical study. , 1991, The Journal of infectious diseases.

[25]  E. Kaplan,et al.  Molecular analysis of pyrogenic exotoxins from Streptococcus pyogenes isolates associated with toxic shock-like syndrome , 1991, Journal of clinical microbiology.

[26]  E. Kaplan,et al.  Outbreak of group A streptococcus septicemia in children. Clinical, epidemiologic, and microbiological correlates. , 1991, JAMA.

[27]  J. Musser,et al.  Streptococcus pyogenes causing toxic-shock-like syndrome and other invasive diseases: clonal diversity and pyrogenic exotoxin expression. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[28]  J. Abramson,et al.  Apparent increase in the incidence of invasive group A beta-hemolytic streptococcal disease in children. , 1991, The Journal of pediatrics.

[29]  B. Schwartz,et al.  Changing epidemiology of group A streptococcal infection in the USA , 1990, The Lancet.

[30]  G. Weinstock,et al.  Comparison of genomic DNAs of different enterococcal isolates using restriction endonucleases with infrequent recognition sites , 1990, Journal of clinical microbiology.

[31]  Martin Pr,et al.  Streptococcal Serogroup: A Epidemic in Norway 1987–1988 , 1990 .

[32]  P. Schlievert,et al.  Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A. , 1989, The New England journal of medicine.

[33]  R. Warren,et al.  Streptococcus pyogenes bacteraemia in Cambridge--a review of 67 episodes. , 1988, The Quarterly journal of medicine.

[34]  K. Carroll,et al.  'Toxic strep syndrome'. A manifestation of group A streptococcal infection. , 1988, Archives of internal medicine.

[35]  G. Colman,et al.  Changes in the pattern of infection caused by Streptococcus pyogenes , 1988, Epidemiology and Infection.

[36]  P. Schlievert,et al.  Clinical and bacteriologic observations of a toxic shock-like syndrome due to Streptococcus pyogenes. , 1987, The New England journal of medicine.

[37]  W. R. Maxted,et al.  Use of the serum-opacity reaction in the typing of group-A streptococci. , 1973, Journal of medical microbiology.

[38]  R. Krause,et al.  NEW APPROACHES FOR THE LABORATORY RECOGNITION OF M TYPES OF GROUP A STREPTOCOCCI , 1971, The Journal of experimental medicine.

[39]  F. Griffith The Serological Classification of Streptococcus pyogenes , 1934, Epidemiology and Infection.